nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Anti-angiogenic therapy in the setting of TACE: an elusive synergy?
|
Odisio, Bruno C |
|
2018 |
3 |
1 |
p. 5-6 |
artikel |
2 |
Capecitabine versus S-1 as adjuvant chemotherapy for patients with stage III colorectal cancer (JCOG0910): an open-label, non-inferiority, randomised, phase 3, multicentre trial
|
Hamaguchi, Tetsuya |
|
2018 |
3 |
1 |
p. 47-56 |
artikel |
3 |
Changing paradigms in adjuvant treatment of colorectal cancer
|
Lordick, Florian |
|
2018 |
3 |
1 |
p. 6-8 |
artikel |
4 |
Correction to Lancet Gastroenterol Hepatol 2017; 2: 877–89
|
|
|
2018 |
3 |
1 |
p. e1 |
artikel |
5 |
Effect of diagnosis, surveillance, and treatment of Barrett's oesophagus on health-related quality of life
|
Britton, James |
|
2018 |
3 |
1 |
p. 57-65 |
artikel |
6 |
Faecal microbiota transplantation versus placebo for moderate-to-severe irritable bowel syndrome: a double-blind, randomised, placebo-controlled, parallel-group, single-centre trial
|
Johnsen, Peter Holger |
|
2018 |
3 |
1 |
p. 17-24 |
artikel |
7 |
Granulocyte colony-stimulating factor and autologous CD133-positive stem-cell therapy in liver cirrhosis (REALISTIC): an open-label, randomised, controlled phase 2 trial
|
Newsome, Philip Noel |
|
2018 |
3 |
1 |
p. 25-36 |
artikel |
8 |
Haemopoietic stem cell therapy in cirrhosis: the end of the story?
|
Lanthier, Nicolas |
|
2018 |
3 |
1 |
p. 3-5 |
artikel |
9 |
Making optical biopsy a clinical reality in colonoscopy
|
East, James E |
|
2018 |
3 |
1 |
p. 10-12 |
artikel |
10 |
Microbiome analysis: ready for clinical use?
|
The Lancet Gastroenterology & Hepatology, |
|
2018 |
3 |
1 |
p. 1 |
artikel |
11 |
Minimum alcohol pricing in Scotland
|
The Lancet Gastroenterology & Hepatology, |
|
2018 |
3 |
1 |
p. 1 |
artikel |
12 |
Of milk and microbes
|
Burki, Talha Khan |
|
2018 |
3 |
1 |
p. 16 |
artikel |
13 |
Orantinib versus placebo combined with transcatheter arterial chemoembolisation in patients with unresectable hepatocellular carcinoma (ORIENTAL): a randomised, double-blind, placebo-controlled, multicentre, phase 3 study
|
Kudo, Masatoshi |
|
2018 |
3 |
1 |
p. 37-46 |
artikel |
14 |
Research in brief
|
Baker, Holly |
|
2018 |
3 |
1 |
p. 15 |
artikel |
15 |
Stool as a treatment for IBS: more questions than answers?
|
Ford, Alexander C |
|
2018 |
3 |
1 |
p. 2-3 |
artikel |
16 |
The painful reality of end-stage liver disease in NASH
|
Ratziu, Vlad |
|
2018 |
3 |
1 |
p. 8-10 |
artikel |
17 |
25th UEG Week
|
Brierley, Rob |
|
2018 |
3 |
1 |
p. 14 |
artikel |
18 |
Too much medicine: overdiagnosis and overtreatment of non-alcoholic fatty liver disease
|
Rowe, Ian A |
|
2018 |
3 |
1 |
p. 66-72 |
artikel |
19 |
What drives the hypoalgesic effect of neurostimulation?
|
Albusoda, Ahmed |
|
2018 |
3 |
1 |
p. 13 |
artikel |